Aurobindo Pharma Ltd. Conference Calls and Earnings Call Transcripts

Aurobindo Pharma Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter
All Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Aurobindo Pharma Ltd.
06 Jun 2020
1100.20
4.75%
Earnings Call Transcript - Q4FY20 for Aurobindo Pharma

Conference Call with Aurobindo Pharma Management and Analysts on Q4FY20 and Full Year Earnings Performance and Outlook. Listen to the full earnings transcript. 

video
 
logo
Aurobindo Pharma Ltd.
24 Feb 2020
1100.20
4.75%
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated February 3, 2020 wherein we have intimated the schedule of Investors/Analysts call on February 7, 2020. We are attaching herewith the Transcript of the analyst / investor call on the Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31, 2019 and the same is being uploaded on the website of the Company and is available in the following web link: https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/
pdf
logo
Aurobindo Pharma Ltd.
28 Nov 2019
1100.20
4.75%
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated November 8, 2019 wherein we have intimated the schedule of Investors/Analysts call on November 13, 2019. We are attaching herewith the Transcript of the analyst / investor call on the Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2019 and the same is being uploaded on the website of the Company and is available in the following web link: https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/
pdf
logo
Aurobindo Pharma Ltd.
19 Aug 2019
1100.20
4.75%
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated August 5, 2019 wherein we have intimated the schedule of Investors/Analysts call on August 8, 2019. We are attaching herewith the Transcript of the analyst / investor call on the Unaudited Financial Results of the Company for the first quarter ended June 30, 2019 and the same is being uploaded on the website of the Company and is available in the following web link: https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/
pdf
logo
Aurobindo Pharma Ltd.
14 Jun 2019
1100.20
4.75%
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated May 24, 2019 wherein we have intimated the schedule of Investors/Analysts call on May 29, 2019. We are attaching herewith the Transcript of the analyst / investor call on the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2019 and the same is being uploaded on the website of the Company and is available in the following web link: https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/
pdf
logo
Aurobindo Pharma Ltd.
22 Feb 2019
1100.20
4.75%
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated February 5, 2019 wherein we have intimated the schedule of Investors/Analysts call on February 8, 2019. We are attaching herewith the Transcript of the analyst / investor call on the un-audited Financial Results of the Company for the third quarter and nine months period ended December 31, 2018 and the same is being uploaded on the website of the Company and is available in the following web link: https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/
pdf
logo
Aurobindo Pharma Ltd.
26 Nov 2018
1100.20
4.75%
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated November 9, 2018 wherein we have intimated the schedule of Investors/Analysts call on November 13, 2018. We are attaching herewith the Transcript of the analyst / investor call on the un-audited Financial Results of the Company for the second quarter and half year ended 30th September, 2018 and the same is being uploaded on the website of the Company and is available in the following web link:...
pdf
logo
Aurobindo Pharma Ltd.
26 Sep 2018
1100.20
4.75%
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Please refer to our letter dated September 6, 2018 wherein we have intimated the schedule of Investors/Analysts call on acquisition of Sandoz's dermatology and oral solids businesses on September 6, 2018. We are attaching herewith the transcript of the analyst / investor call and the same is being uploaded on the website of the Company and is available in the following web link: http://www.aurobindo.com/investor-relations/investors/investor-presentation
pdf
logo
Aurobindo Pharma Ltd.
20 Aug 2018
1100.20
4.75%
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated August 7, 2018 wherein we have intimated the schedule of Investors/Analysts call on August 10, 2018. We are attaching herewith the Transcript of the analyst / investor call on the un-audited Financial Results of the Company for the first quarter ended 30th June, 2018 and the same is being uploaded on the website of the Company and is available in the following web link: http://www.aurobindo.com/investor-relations/finance/financial-results
pdf
logo
Aurobindo Pharma Ltd.
18 Jun 2018
1100.20
4.75%
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Dear Sirs, Sub: Transcript of earnings call. Please refer to our letter dated 28th May, 2018 wherein we have intimated the schedule of Investors/Analysts call on 29th May, 2018. We are attaching herewith the Transcript of the analyst / investor call on the Audited Financial Results of the Company for the Year ended 31st March, 2018 of 29th May, 2018 and the same is being uploaded on the website...
pdf

Earnings Calls Podcast on